Non-Invasive test may predict liver transplant failure in real time
NCT ID NCT07658794
First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 2 times
Summary
This study explores whether a non-invasive test called the vascular occlusion test (VOT), used with near-infrared spectroscopy, can predict early allograft dysfunction (EAD) in adults receiving a liver transplant. EAD is a serious complication that can lead to organ failure. Researchers will measure oxygen levels in tissues at several points during surgery and see if those readings can forecast EAD within the first week after transplant. The goal is to find a reliable way to spot trouble early, so doctors can intervene sooner.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this test could give doctors a real-time warning during surgery, potentially improving outcomes for liver transplant patients.
- What could go wrong
- This is a small observational study, so results may not apply to all patients. The test might not reliably predict graft dysfunction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EARLY ALLOGRAFT DYSFUNCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Thessaloniki, 54642, Greece
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- A new procedure may offer relief for Cirrhosis-Related fluid buildup
- Can liver damage predict how drugs behave?
- Better crystal ball for liver crisis: new scores put to the test
- Blood thinner may stop early cirrhosis from turning deadly — a major trial puts it to the test
- Stick-On ultrasound patch could spot liver damage without a specialist